G. Vagheggini (Volterra (PI), Italy), R. Evans (Leicester (Leicestershire), United Kingdom)
This session is built from abstracts published on the ERS Congress platform from 23 August, in a PowerPoint format with a pre-recorded audio narration. The live session is scheduled from September 5-7 and each presenter will have a 5-minutes live, slide show presentation followed at the end of the session by 30-minutes general discussion.
’Can do, do do’ concept and all-cause mortality risk in patients with COPD
A. Vaes (Horn, Netherlands), M. Spruit (Horn, Netherlands), H. Van Hees (Nijmegen, Netherlands), E. Koolen (Nijmegen, Netherlands), J. Antons (Nijmegen, Netherlands), M. De Man (Uden, Netherlands), R. Djamin (Breda, Netherlands), A. Van 'T Hul (Nijmegen, Netherlands)
|    |
Behavioural modification interventions alongside pulmonary rehabilitation improve COPD patients’ experiences of physical activity
M. Armstrong (Newcastle Upon Tyne, United Kingdom), E. Hume (Newcastle Upon Tyne, United Kingdom), L. Mcneille (Newcastle Upon Tyne, United Kingdom), F. Chambers (Newcastle Upon Tyne, United Kingdom), L. Wakenshaw (Newcastle Upon Tyne, United Kingdom), G. Burns (Newcastle Upon Tyne, United Kingdom), K. Heslop-Marshall (Newcastle Upon Tyne, United Kingdom), I. Vogiatzis (Newcastle Upon Tyne, United Kingdom)
| |
Proposed MID in FACIT and VAS scores for individuals attending COVID-19 rehabilitation.
C. Gerlis (Leicester, United Kingdom), S. Singh (Leicester, United Kingdom), N. Gardiner (Leicester, United Kingdom), L. Houchen-Wolloff (Leicester, United Kingdom), E. Chaplin (Leicester, United Kingdom), E. Daynes (Leicester, United Kingdom)
| |
RISK FACTORS FOR THE DEVELOPMENT OF SARCOPENIA IN PATIENTS WITH COVID-19
D. Gonzalez ISLAS (Ciudad de México, Mexico), C. Sánchez-Moreno (Ciudad de México, Mexico), A. Orea-Tejeda (Ciudad de México, Mexico), M. Salgado-Fernández (Ciudad de México, Mexico), A. Hernández-López (Ciudad de México, Mexico), S. Galicia-Amor (Ciudad de México, Mexico), E. Trejo-Mellado (Ciudad de México, Mexico), J. García-Hernández (Ciudad de México, Mexico), J. Orozco-Gutiérrez (Ciudad de México, Mexico), C. Aboitiz-Rivera (Ciudad de México, Mexico)
| |
Altered calcium response in stimulated myotubes from COPD patients
P. Pomiès (Montpellier Cedex 5, France), A. Virsolvy (Montpellier Cedex 5, France), E. Passerieux (Montpellier Cedex 5, France), B. Ayoub (Montpellier Cedex 5, France), M. Hayot (Montpellier Cedex 5, France)
| |
The sound of anxiety: exploring the effect of audio recordings of breathing on self-reported breathlessness
N. Lovell (London, United Kingdom), S. Etkind (London, United Kingdom), W. Prentice (London, United Kingdom), I. Higginson (London, United Kingdom), K. Sleeman (London, United Kingdom), S. Etkind (Cambridge, United Kingdom)
| |
Outcomes of Multi Disciplinary Team Comprehensive Post Hospitalisation Follow Up for 420 COVID 19 Patients
Y. Noeman Ahmed (SouthendSSouthendouthend, United Kingdom), K. Milan (Southend University Hospital, United Kingdom), M. Noeman (London, United Kingdom), D. Alsouki (Southend University Hospital, United Kingdom), M. Kotouckova (Southend University Hospital, United Kingdom), G. Koduri (Southend University Hospital, United Kingdom), D. Amran (Southend University Hospital, United Kingdom), D. Powrie (Southend University Hospital, United Kingdom)
| |
Effect of high-flow oxygen therapy on exercise tolerance in idiopathic pulmonary fibrosis: a randomized crossover trial.
J. Harada (Kobe, Japan), K. Nagata (Kobe, Japan), K. Iwata (Kobe, Japan), A. Ishikawa (Kobe, Japan), K. Tomii (Kobe, Japan)
| |
Comprehensive pulmonary rehabilitation (PR) decreases frailty in lung transplant recipients – a prospective observational study
T. Schneeberger (Schönau am Königssee, Germany), M. Gaida (Schönau am Königssee, Germany), I. Jarosch (Schönau am Königssee, Germany), D. Leitl (Schönau am Königssee, Germany), R. Gloeckl (Schönau am Königssee, Germany), K. Kenn (Schönau am Königssee, Germany), A. Koczulla (Schönau am Königssee, Germany)
| |
Late Breaking Abstract - A randomised control trial using inspiratory muscle training in post-COVID-19 rehabilitation
M. McNarry (Swansea, United Kingdom), J. Shelley (Swansea, United Kingdom), J. Hudson (Swansea, United Kingdom), Z. Saynor (Portsmouth, United Kingdom), J. Duckers (Cardiff, United Kingdom), K. Lewis (Llanelli, United Kingdom), G. Davies (Swansea, United Kingdom), M. Williams (Treforest, United Kingdom), R. Berg (Copenhagen, United Kingdom), K. Mackintosh (Swansea, United Kingdom)
| |
Discussion
| |